Literature DB >> 19191909

Effect of bone morphogenetic protein-6 on macrophages.

Jun Hyuk Hong1, Geun Taek Lee, Jae Ho Lee, Seok Joo Kwon, Seok Hee Park, Seong Jin Kim, Isaac Yi Kim.   

Abstract

Bone morphogenetic proteins (BMPs) are members of the transforming growth factor (TGF)-beta superfamily which regulates bone formation, haematopoiesis and development. While TGF-beta is known to be a negative regulator of the immune system, the effect of BMPs on the immune system is largely unknown. Herein, the effect of BMP-6 on the innate immune system was investigated using the murine macrophage cell line RAW 264.7. BMP-6 altered cellular morphology, inhibited cellular proliferation, increased the fraction of subG(1) phase cells, and decreased the fraction of cells in the S and G(2)M phases, without changing the percentage of apoptotic cells. In addition, BMP-6 induced expression of pro-inflammatory inducible nitric oxide synthase (iNOS) and the cytokine tumour necrosis factor (TNF)-alpha. Reverse transcription-polymerase chain reaction (RT-PCR) analysis demonstrated the expression of all three known type II BMP receptors [BMP-RII, activin (Act)-RIIA and Act-RIIB] and two of the three known type I receptors [activin receptor-like kinase 2 (ALK2) and ALK3]. Over-expression as well as knock-down studies using short hairpin RNA (shRNA) demonstrated that BMP-RII, ALK2 and ALK3 are the functional BMP-6 receptors in macrophages. Finally, the effect of BMP-6 was confirmed in murine peritoneal macrophages and the THP-1 human monocyte cell line. Taken together, these results demonstrate that BMP-6 regulates the proliferation and gene expression profile of macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19191909      PMCID: PMC2753950          DOI: 10.1111/j.1365-2567.2008.02998.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

Review 1.  Consequences of knocking out BMP signaling in the mouse.

Authors:  Guang-Quan Zhao
Journal:  Genesis       Date:  2003-01       Impact factor: 2.487

Review 2.  Signal transduction of bone morphogenetic protein receptors.

Authors:  Anja Nohe; Eleonora Keating; Petra Knaus; Nils O Petersen
Journal:  Cell Signal       Date:  2004-03       Impact factor: 4.315

Review 3.  BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.

Authors:  Kohei Miyazono; Shingo Maeda; Takeshi Imamura
Journal:  Cytokine Growth Factor Rev       Date:  2005-06       Impact factor: 7.638

4.  Lentivirus-delivered stable gene silencing by RNAi in primary cells.

Authors:  Sheila A Stewart; Derek M Dykxhoorn; Deborah Palliser; Hana Mizuno; Evan Y Yu; Dong Sung An; David M Sabatini; Irvin S Y Chen; William C Hahn; Phillip A Sharp; Robert A Weinberg; Carl D Novina
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

5.  Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.

Authors:  Isaac Yi Kim; Dong-Hyeon Lee; Dug Keun Lee; Byung Chul Kim; Heung Tae Kim; Fredrick S Leach; W Marston Linehan; Ronald A Morton; Seong Jin Kim
Journal:  Clin Cancer Res       Date:  2003-12-01       Impact factor: 12.531

6.  Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells.

Authors:  Einar A Sivertsen; Kanutte Huse; Marit E Hystad; Christian Kersten; Erlend B Smeland; June H Myklebust
Journal:  Eur J Immunol       Date:  2007-10       Impact factor: 5.532

7.  XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization.

Authors:  Miao Lu; Su-Chang Lin; Yihua Huang; Young Jun Kang; Rebecca Rich; Yu-Chih Lo; David Myszka; Jiahuai Han; Hao Wu
Journal:  Mol Cell       Date:  2007-06-08       Impact factor: 17.970

Review 8.  Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex.

Authors:  Mitsuhiro Fujihara; Masashi Muroi; Ken-ichi Tanamoto; Tsuneo Suzuki; Hiroshi Azuma; Hisami Ikeda
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

Review 9.  Transforming growth factor-beta regulation of immune responses.

Authors:  Ming O Li; Yisong Y Wan; Shomyseh Sanjabi; Anna-Karin L Robertson; Richard A Flavell
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

10.  BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1.

Authors:  Gail A Wong; Vincent Tang; Faten El-Sabeawy; Robert H Weiss
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-01-14       Impact factor: 4.310

View more
  30 in total

1.  CREBZF, a novel Smad8-binding protein.

Authors:  Jae-Ho Lee; Geun Taek Lee; Seok Joo Kwon; Jeongyun Jeong; Yun-Sok Ha; Wun-Jae Kim; Isaac Yi Kim
Journal:  Mol Cell Biochem       Date:  2012-06-16       Impact factor: 3.396

2.  Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis.

Authors:  Xinchun Pi; Pamela Lockyer; Laura A Dyer; Jonathan C Schisler; Brooke Russell; Stephen Carey; Daniel Timothy Sweet; Zhongming Chen; Ellie Tzima; Monte S Willis; Jonathon W Homeister; Martin Moser; Cam Patterson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-05       Impact factor: 8.311

3.  Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages.

Authors:  Yin Xia; Virna Cortez-Retamozo; Vera Niederkofler; Rishard Salie; Shanzhuo Chen; Tarek A Samad; Charles C Hong; Silvia Arber; Jatin M Vyas; Ralph Weissleder; Mikael J Pittet; Herbert Y Lin
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

Review 4.  Immunoregulation by members of the TGFβ superfamily.

Authors:  WanJun Chen; Peter Ten Dijke
Journal:  Nat Rev Immunol       Date:  2016-11-25       Impact factor: 53.106

5.  The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.

Authors:  Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

6.  Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis.

Authors:  Amélie Dendooven; Olivia van Oostrom; Dionne M van der Giezen; Jan Willem Leeuwis; Cristel Snijckers; Jaap A Joles; Elizabeth J Robertson; Marianne C Verhaar; Tri Q Nguyen; Roel Goldschmeding
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

7.  Induction of interleukin-6 expression by bone morphogenetic protein-6 in macrophages requires both SMAD and p38 signaling pathways.

Authors:  Geun Taek Lee; Seok Joo Kwon; Jae-Ho Lee; Seong Soo Jeon; Kee Taek Jang; Han Yong Choi; Hyun Moo Lee; Wun-Jae Kim; Seong Jin Kim; Isaac Yi Kim
Journal:  J Biol Chem       Date:  2010-10-01       Impact factor: 5.157

8.  Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophages.

Authors:  Geun Taek Lee; Yeon Suk Jung; Yun-Sok Ha; Jeong Hyun Kim; Wun-Jae Kim; Isaac Y Kim
Journal:  Cancer Sci       Date:  2013-06-28       Impact factor: 6.716

9.  Ambivalent effects of compound C (dorsomorphin) on inflammatory response in LPS-stimulated rat primary microglial cultures.

Authors:  Krzysztof Labuzek; Sebastian Liber; Bozena Gabryel; Lukasz Bułdak; Bogusław Okopień
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-26       Impact factor: 3.000

10.  Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation.

Authors:  Yoshitaka Eguchi; Shigeyuki Wakitani; Yuuki Imai; Yoshifumi Naka; Yuusuke Hashimoto; Hiroaki Nakamura; Kunio Takaoka
Journal:  J Bone Miner Metab       Date:  2009-10-29       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.